BACKGROUND: Ulipristal (UPA; CDB-2914) is a progesterone receptor modulator with contraceptive potential. To test its effects when delivered by an intrauterine system (IUS), we prepared control and UPA-filled IUS and evaluated their effects in rhesus macaques. STUDY DESIGN: Short lengths of Silastic tubing either empty (n=3) or containing UPA (n=5) were inserted into the uteri of 8 ovariectomized macaques. Animals were cycled by sequential treatment with estradiol and progesterone. After 3.5 cycles, the uterus was removed. RESULTS: During treatment, animals with an empty IUS menstruated for a mean total of 11.66+/-0.88 days, while UPA-IUS treated animals bled for only 1+/-0.45 days. Indices of endometrial proliferation were significantly reduced by UPA-IUS treatment. The UPA exposed endometria were atrophied with some glandular cysts while the blank controls displayed a proliferative morphology without cysts. Androgen receptors were more intensely stained in the glands of the UPA-IUS treated endometria than in the blank-IUS treated controls. CONCLUSIONS: In rhesus macaques, a UPA-IUS induced endometrial atrophy and amenorrhea. The work provides proof of principle that an IUS can deliver effective intrauterine concentrations of Ulipristal. Copyright 2010 Elsevier Inc. All rights reserved.
BACKGROUND: Ulipristal (UPA; CDB-2914) is a progesterone receptor modulator with contraceptive potential. To test its effects when delivered by an intrauterine system (IUS), we prepared control and UPA-filled IUS and evaluated their effects in rhesus macaques. STUDY DESIGN: Short lengths of Silastic tubing either empty (n=3) or containing UPA (n=5) were inserted into the uteri of 8 ovariectomized macaques. Animals were cycled by sequential treatment with estradiol and progesterone. After 3.5 cycles, the uterus was removed. RESULTS: During treatment, animals with an empty IUS menstruated for a mean total of 11.66+/-0.88 days, while UPA-IUS treated animals bled for only 1+/-0.45 days. Indices of endometrial proliferation were significantly reduced by UPA-IUS treatment. The UPA exposed endometria were atrophied with some glandular cysts while the blank controls displayed a proliferative morphology without cysts. Androgen receptors were more intensely stained in the glands of the UPA-IUS treated endometria than in the blank-IUS treated controls. CONCLUSIONS: In rhesus macaques, a UPA-IUS induced endometrial atrophy and amenorrhea. The work provides proof of principle that an IUS can deliver effective intrauterine concentrations of Ulipristal. Copyright 2010 Elsevier Inc. All rights reserved.
Authors: George L Mutter; Christine Bergeron; Liane Deligdisch; Alex Ferenczy; Mick Glant; Maria Merino; Alistair R W Williams; Diana L Blithe Journal: Mod Pathol Date: 2008-02-08 Impact factor: 7.842
Authors: Barbara J Attardi; Janet Burgenson; Sheri A Hild; Jerry R Reel; Richard P Blye Journal: Mol Cell Endocrinol Date: 2002-02-25 Impact factor: 4.102
Authors: O D Slayden; N R Nayak; K A Burton; K Chwalisz; S T Cameron; H O Critchley; D T Baird; R M Brenner Journal: J Clin Endocrinol Metab Date: 2001-06 Impact factor: 5.958
Authors: L H R Whitaker; A A Murray; R Matthews; G Shaw; A R W Williams; P T K Saunders; H O D Critchley Journal: Hum Reprod Date: 2017-03-01 Impact factor: 6.918
Authors: Andrea Wagenfeld; Philippa T K Saunders; Lucy Whitaker; Hilary O D Critchley Journal: Expert Opin Ther Targets Date: 2016-05-14 Impact factor: 6.902